Delcath Systems (DCTH) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
2 Apr, 2026Executive summary
Annual Meeting scheduled virtually for May 13, 2026, at 10:00 a.m. EDT for all stockholders.
Proxy materials and annual report are available online, with options for paper or email copies upon request.
Stockholders can vote online before or during the meeting using a unique control number.
Voting matters and shareholder proposals
Election of John Sylvester and Elizabeth Czerepak as Class II directors for terms expiring in 2029.
Approval sought to amend the 2020 Omnibus Equity Incentive Plan, increasing available shares by 1,800,000.
Ratification of CBIZ CPAS P.C. as independent registered public accounting firm for fiscal year ending December 31, 2026.
Advisory vote on executive compensation for named executive officers.
Board of directors and corporate governance
Board recommends voting in favor of all four proposals presented at the meeting.
Directors up for election will serve until 2029 or until a successor is appointed.
Latest events from Delcath Systems
- Annual meeting to vote on directors, equity plan, auditor, and executive pay, all Board-recommended.DCTH
Proxy filing2 Apr 2026 - Record $85.2M revenue, positive net income, and strong 2026 growth outlook.DCTH
Q4 202526 Feb 2026 - Q2 revenue hit $7.8M with 80% margin; net loss widened, but U.S. growth and NTAP boost outlook.DCTH
Q2 20242 Feb 2026 - Q3 revenue hit $11.2M, net income $1.9M, and $25M raised from warrants; all debt eliminated.DCTH
Q3 202415 Jan 2026 - Registration allows up to $150M in securities to fund oncology growth and operations.DCTH
Registration Filing16 Dec 2025 - Board recommends approval of all proposals, including director elections and plan amendments.DCTH
Proxy Filing2 Dec 2025 - Virtual Annual Meeting to vote on directors, equity plans, auditor, and executive pay.DCTH
Proxy Filing2 Dec 2025 - FY2024 revenue hit $37.2M, driven by HEPZATO KIT and positive Q4 adjusted EBITDA.DCTH
Q4 20241 Dec 2025 - Q1 2025 saw $19.8M revenue, $1.1M net income, and strong U.S. expansion.DCTH
Q1 202526 Nov 2025